Catalent
To Catalent Pharma Solutions next and the firm has named David Heyens (left) in the new role of President of Catalent Asia Pacific.
Heyens has been with Catalent since 1995 and has served as President of Catalent’s Softgel Technologies business since 2007.
“This appointment comes at an important moment in our business, as we launch our two new joint ventures in China, for softgel technologies and clinical supplies, and focus more growth resources in Asia Pacific,” said Catalent’s CEO John Chiminski.
Dr. Aris Gennadios (right) will replace Heyens and will be responsible for global softgel development, delivery and supply business with Catalent’s 10 global manufacturing facilities.
Chiminskisaid: “We are very excited to have him join our executive team and extend the momentum and growth that we are driving in our flagship business.”
And Catalent made the news recently with the integration of its core drug delivery services into a new unit. Read about it here.